These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


116 related items for PubMed ID: 3285132

  • 21. Novel spirosuccinimide aldose reductase inhibitors derived from isoquinoline-1,3-diones: 2-[(4-bromo-2-fluorophenyl)methyl]-6- fluorospiro[isoquinoline-4(1H),3'-pyrrolidine]-1,2',3,5'(2H)-tetrone and congeners. 1.
    Malamas MS, Hohman TC, Millen J.
    J Med Chem; 1994 Jun 24; 37(13):2043-58. PubMed ID: 8027986
    [Abstract] [Full Text] [Related]

  • 22. Effect of pyruvate on lens myo-inositol transport and polyol formation in diabetic cataract.
    Beyer-Mears A, Diecke FP, Mistry K, Ellison C, Cruz E.
    Pharmacology; 1997 Aug 24; 55(2):78-86. PubMed ID: 9323307
    [Abstract] [Full Text] [Related]

  • 23. Polyol formation in cell lines of rat retinal capillary pericytes and endothelial cells (TR-rPCT and TR-iBRB).
    Kador PF, Randazzo J, Blessing K, Makita J, Zhang P, Yu K, Hosoya K, Terasaki T.
    J Ocul Pharmacol Ther; 2009 Aug 24; 25(4):299-308. PubMed ID: 19450153
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Acetyl-L-carnitine corrects electroretinographic deficits in experimental diabetes.
    Lowitt S, Malone JI, Salem A, Kozak WM, Orfalian Z.
    Diabetes; 1993 Aug 24; 42(8):1115-8. PubMed ID: 8325441
    [Abstract] [Full Text] [Related]

  • 27. Polyol accumulation in galactosemic and diabetic rats: control by an aldose reductase inhibitor.
    Dvornik E, Simard-Duquesne N, Krami M, Sestanj K, Gabbay KH, Kinoshita JH, Varma SD, Merola LO.
    Science; 1973 Dec 14; 182(4117):1146-8. PubMed ID: 4270794
    [Abstract] [Full Text] [Related]

  • 28. Abnormalities of retinal metabolism in diabetes and experimental galactosemia. VII. Effect of long-term administration of antioxidants on the development of retinopathy.
    Kowluru RA, Tang J, Kern TS.
    Diabetes; 2001 Aug 14; 50(8):1938-42. PubMed ID: 11473058
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Demonstration that polyol accumulation is responsible for diabetic cataract by the use of transgenic mice expressing the aldose reductase gene in the lens.
    Lee AY, Chung SK, Chung SS.
    Proc Natl Acad Sci U S A; 1995 Mar 28; 92(7):2780-4. PubMed ID: 7708723
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Retinopathy in galactosemic dogs continues to progress after cessation of galactosemia.
    Engerman RL, Kern TS.
    Arch Ophthalmol; 1995 Mar 28; 113(3):355-8. PubMed ID: 7887850
    [Abstract] [Full Text] [Related]

  • 35. Effect of propionyl-L-carnitine on oscillatory potentials in electroretinogram in streptozotocin-diabetic rats.
    Hotta N, Koh N, Sakakibara F, Nakamura J, Hamada Y, Hara T, Fukasawa H, Kakuta H, Sakamoto N.
    Eur J Pharmacol; 1996 Sep 12; 311(2-3):199-206. PubMed ID: 8891600
    [Abstract] [Full Text] [Related]

  • 36. Effects of aldose reductase inhibitor (M79175) on ERG oscillatory potential abnormalities in streptozotocin fructose-induced diabetes in rats.
    Funada M, Okamoto I, Fujinaga Y, Yamana T.
    Jpn J Ophthalmol; 1987 Sep 12; 31(2):305-14. PubMed ID: 3118085
    [Abstract] [Full Text] [Related]

  • 37. The role of cyclic adenosine 3',5'-monophosphate and polyol metabolism in diabetic neuropathy.
    Shindo H, Tawata M, Aida K, Onaya T.
    J Clin Endocrinol Metab; 1992 Feb 12; 74(2):393-8. PubMed ID: 1370506
    [Abstract] [Full Text] [Related]

  • 38. Ascorbic acid metabolism and polyol pathway in diabetes.
    Yue DK, McLennan S, Fisher E, Heffernan S, Capogreco C, Ross GR, Turtle JR.
    Diabetes; 1989 Feb 12; 38(2):257-61. PubMed ID: 2492477
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 6.